News in brief - August 2014

Other new launches, licence changes and updates relevant to general practice.

Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
  • Janssen-Cilag has launched Sylvant (siltuximab) for the treatment of multicentric Castleman's disease in adults who are HIV-negative and human herpesvirus-8 negative.
  • The cold sore cream Fenistil (penciclovir) has been reclassified from a P medicine to a GSL.
  • Arzerra (ofatumumab) is now indicated in combination with chlorambucil or bendamustine for the treatment of chronic lymphocytic leukaemia in previously untreated patients ineligible for fludarabine-based therapy.

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

Cases of necrotising fasciitis of the genitalia or...

New advice for carbimazole over malformation and pancreatitis risks

New advice for carbimazole over malformation and pancreatitis risks

Reports of congenital malformations and acute pancreatitis...

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Antibiotic Treatments in Adults, Summary of Regimens

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.